Page last updated: 2024-10-22

amiodarone and Anemia, Hemolytic

amiodarone has been researched along with Anemia, Hemolytic in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mironchik, EV1
Dolgosheĭ, TS1
Liskovich, TG1
Madeshkina, GA1
Kokhkovski, AB1
Tyshchenko, AD1
Hesselmann, J1
Huep, WW1
Schröder, E1

Other Studies

2 other studies available for amiodarone and Anemia, Hemolytic

ArticleYear
[Long QT syndrome induced by cordaron and quinidine].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:3

    Topics: Amiodarone; Anemia, Hemolytic; Anti-Arrhythmia Agents; Female; Humans; Hypertension; Long QT Syndrom

2007
[Life threatening alveolitis and hemolysis following amiodarone].
    Die Medizinische Welt, 1983, Aug-12, Volume: 34, Issue:31-32

    Topics: Amiodarone; Anemia, Hemolytic; Benzofurans; Cardiac Complexes, Premature; Heart Failure; Humans; Mal

1983